Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
Show-Harness: Just a VLM Agent Can Play Robots
arXiv:2609.10522v1 Announce Type: cross Abstract: Foundation vision-language models (VLMs) exhibit broad intelligence about the world, yet translating this intelligence into robot control remains challenging. We present Show-Harness, an Embodied Harness that enables VLMs to "play" robots through a compact semantic interface linking intent to action. Show-Harness exposes discrete semantic action units that VLMs can naturally reason over, while embodiment-specific interpreters deterministically g
-
cs.AI, q-bio.NC updates on arXiv.org
-
Meta-Soft: Leveraging Composable Meta-Tokens for Context-Preserving KV Cache Compression
arXiv:2605.22337v2 Announce Type: replace Abstract: The KV cache used in large language models has linearly growing time complexity, so LLMs face memory blow-up and reduced decoding efficiency when they process long contexts. Current KV Cache eviction has become an important research direction; however, existing methods based on fixed Soft Tokens (e.g., Judge Q) rely on a static parameter set as the query to evaluate the importance of KV pairs, so they cannot adapt dynamically to different inpu
Meta-Soft: Leveraging Composable Meta-Tokens for Context-Preserving KV Cache Compression
-
Omics in Hepatocellular
-
Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma
Int Immunopharmacol. 2026 May 19;183:116866. doi: 10.1016/j.intimp.2026.116866. Online ahead of print.ABSTRACTHepatocellular carcinoma (HCC) is a lethal malignancy with a high recurrence rate and limited treatment options. Ubiquitin-conjugating enzyme E2 C (UBE2C) is implicated in various cancers, yet its impact on the HCC immune landscape remains incompletely understood. Herein, hub genes in HCC were identified, by integrating co-expression networks and protein-protein interaction analyses, fro
Integrative multi-omics and experimental validation reveal UBE2C as a central hub gene and prognostic biomarker in hepatocellular carcinoma
Int Immunopharmacol. 2026 May 19;183:116866. doi: 10.1016/j.intimp.2026.116866. Online ahead of print.
ABSTRACT
Hepatocellular carcinoma (HCC) is a lethal malignancy with a high recurrence rate and limited treatment options. Ubiquitin-conjugating enzyme E2 C (UBE2C) is implicated in various cancers, yet its impact on the HCC immune landscape remains incompletely understood. Herein, hub genes in HCC were identified, by integrating co-expression networks and protein-protein interaction analyses, from the TCGA, GEO, and CPTAC databases. Their expression was analysed using a single-cell transcriptomic database and verified in HCC tissues and cell lines via quantitative reverse transcription-PCR and immunoblotting. Functional roles of UBE2C were assessed using in vitro knockdown experiments and an in vivo subcutaneous tumour model. The tumour immune microenvironment was profiled using spatial transcriptomics, RNA-seq data, and ssGSEA. A prognostic nomogram was constructed based on multivariate Cox regression. UBE2C was identified as a significantly upregulated hub gene in HCC. Single-cell RNA-seq revealed predominant expression of UBE2C in hepatocytes, with dynamic upregulation along differentiation trajectories. UBE2C knockdown suppressed proliferation, induced apoptosis, and inhibited tumour growth. Spatial transcriptomics highlighted UBE2C-high regions within proliferative niches exhibiting immunosuppressive traits-including TGFB1 enrichment, impaired CXCL9-CXCR3 signalling, and exclusion of cytotoxic T cells-which were reduced in immunotherapy responders. UBE2C expression correlated with immune checkpoint genes and specific immune cell subsets. A UBE2C-based nomogram integrating T stage and tumour stage robustly predicted patient survival, and miR-300 and miR-381-3p were identified as potential upstream regulators. These findings establish UBE2C as a key driver of HCC progression and a biomarker for prognosis and immunotherapy stratification.
PMID:42155390 | DOI:10.1016/j.intimp.2026.116866
-
Nature - Issue - nature.com science feeds
-
A spatial atlas of the healthy human liver from live donors
Nature, Published online: 15 April 2026; doi:10.1038/s41586-026-10377-yA human spatial atlas of gene expression in liver based on live donors shows marked porto–central zonation of hepatocytes and non-parenchymal cells, and transcriptomic changes in early steatosis.
A spatial atlas of the healthy human liver from live donors
Nature, Published online: 15 April 2026; doi:10.1038/s41586-026-10377-y
A human spatial atlas of gene expression in liver based on live donors shows marked porto–central zonation of hepatocytes and non-parenchymal cells, and transcriptomic changes in early steatosis.-
cs.AI, q-bio.NC updates on arXiv.org
-
RubricBench: Aligning Model-Generated Rubrics with Human Standards
arXiv:2603.01562v2 Announce Type: replace Abstract: As Large Language Model (LLM) alignment evolves from simple completions to complex, highly sophisticated generation, Reward Models are increasingly shifting toward rubric-guided evaluation to mitigate surface-level biases. However, the community lacks a unified benchmark to assess this evaluation paradigm, as existing benchmarks lack both the discriminative complexity and the ground-truth rubric annotations required for rigorous analysis. To b
RubricBench: Aligning Model-Generated Rubrics with Human Standards
-
cs.AI, q-bio.NC updates on arXiv.org
-
Dataset Distillation via Committee Voting
arXiv:2501.07575v2 Announce Type: replace-cross Abstract: Dataset distillation aims to synthesize a compact yet representative dataset that preserves the essential characteristics of the original data for efficient model training. Existing methods mainly focus on improving data-synthetic alignment or scaling distillation to large datasets. In this work, we propose $\textbf{C}$ommittee $\textbf{V}$oting for $\textbf{D}$ataset $\textbf{D}$istillation ($\textbf{CV-DD}$), an orthogonal approach tha